Ubrogepant

Modify Date: 2024-01-02 18:59:55

Ubrogepant Structure
Ubrogepant structure
Common Name Ubrogepant
CAS Number 1374248-77-7 Molecular Weight 549.54400
Density 1.45±0.1 g/cm3(Predicted) Boiling Point 729.4±60.0 °C(Predicted)
Molecular Formula C29H26F3N5O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Ubrogepant


Ubrogepant (MK-1602) is a novel oral calcitonin gene-related peptide receptor (CGRP) antagonist in development for acute treatment of migraine[1].

 Names

Name (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.45±0.1 g/cm3(Predicted)
Boiling Point 729.4±60.0 °C(Predicted)
Molecular Formula C29H26F3N5O3
Molecular Weight 549.54400
Exact Mass 549.19900
PSA 111.27000
LogP 4.12840

 Synonyms

(3'S)-N-((3S,5S,6R)-6-Methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro(cyclopenta(b)pyridine-6,3'-pyrrolo(2,3-b)pyridine)-3-carboxamide
Spiro(6H-cyclopenta(b)pyridine-6,3'-(3H)pyrrolo(2,3-b)pyridine)-3-carboxamide,1',2',5,7-tetrahydro-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl)-2'-oxo-,(3'S)
Ubrogepant [USAN]
MK-1602
Ubrogepant
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Ubrogepant suppliers

Ubrogepant price